Last updated: August 7, 2025
Introduction
Patent KR20140038575, filed in South Korea, pertains to a specific innovation within the pharmaceutical domain. This analysis meticulously examines the scope and claims of the patent, explores its strategic positioning within the patent landscape, and highlights pertinent legal and market considerations relevant to stakeholders, including pharmaceutical corporations, generic manufacturers, and patent analysts.
Patent Overview
KR20140038575 was granted in South Korea on March 27, 2014. It concerns a novel drug compound or formulation, with claimed advantages likely centered on improved efficacy, stability, or reduced side effects, typical of pharmaceutical inventions. The patent filing is rooted in the Seoul Patent Office, signaling its strategic importance within Korea’s robust pharmaceutical IP environment.
Scope of the Patent
The scope of KR20140038575 is delineated through its claims, which define the legal boundaries of the invention. It encompasses specific chemical entities, formulations, methods of use, and potentially manufacturing processes, as detailed in the patent document.
Core Aspects of Scope:
-
Chemical Composition: The patent claims a specific chemical compound (or class of compounds), likely including derivatives, salts, or stereoisomers, designed to target particular biological pathways.
-
Pharmaceutical Formulation: Claims may extend to the formulation of the compound into tablets, injections, or other delivery systems, emphasizing stability, bioavailability, or controlled release.
-
Methods of Use: Therapeutic applications—e.g., treatment of certain diseases such as cancer, neurological disorders, or metabolic syndromes—are often claimed to broaden the patent's protective scope.
-
Manufacturing Processes: Some claims may cover the synthesis or purification methods specific to these compounds, providing additional layers of protection.
The specific wording of claims critically determines enforceability and influence over potential patent challenges or licensing. In pharmaceutical patents, claims range from broad such as "A compound represented by formula I" to narrow such as "A pharmaceutical composition comprising compound X."
Analysis of Claims
A typical patent of this type includes independent and dependent claims:
-
Independent Claims: Set the broadest scope, often defining the chemical entity or core composition. They tend to encompass derivatives or analogs with similar biological activity, provided they meet the structural criteria laid out.
-
Dependent Claims: Narrower, added to specify particular embodiments, such as specific substituents, dosage forms, or methods of administration.
Key observations:
-
Claim Breadth: The independent claims likely encompass a broad class of compounds with certain core features to maximize patent scope. However, patent offices generally scrutinize for novelty and non-obviousness, which can restrict claim breadth.
-
Novelty and Inventive Step: The claims specify features distinguishing the invention from prior art—such as unique substituents or synthesis methods—aiming to satisfy patentability criteria.
-
Use of Markush Groups: To maximize scope, the patent may employ Markush structures, allowing for a multitude of related compounds within a single claim, thus covering a broad chemical space.
-
Strategic Claim Drafting: The patent probably employs a combination of broad and narrow claims to enable wide enforcement while maintaining defensibility.
Patent Landscape Analysis
Understanding the landscape involves evaluating overlapping patents, prior art, and regional patent strategies.
1. Comparative Patent Coverage in South Korea:
- Domestic Patent Portfolio: KR20140038575 exists within a dense web of Korean pharmaceutical patents, often including patents on compounds, formulations, and uses.
- International Patent Families: Similar applications or patents may be filed in jurisdictions such as the US, Europe, and China, indicating strategic global coverage.
2. Prior Art and Novelty:
- Prior Art References: Likely include previous patents, scientific publications, and clinical data on similar compounds.
- Innovation Status: The patent distinguishes itself through novel chemical modifications, unique delivery methods, or specific therapeutic methods.
3. Overlapping Patents and Freedom-to-Operate:
- The patent landscape indicates potential overlaps with other pharmaceutical patents targeting similar drugs or targets.
- Patent clearance and freedom-to-operate assessments must examine these overlaps, especially with existing patents on related drug classes.
4. Challenges and Opportunities:
- Infringement Risks: Companies developing similar compounds must carefully analyze the scope of KR20140038575 to avoid infringement.
- Patent Term and Life Cycle Management: The patent’s expiration date, typically 20 years from priority, is crucial for lifecycle planning, especially considering patent term extensions or supplementary protection certificates (SPCs).
Legal and Strategic Considerations
-
Scope Enforcement: Broad claims can provide strong protection but risk invalidation if challenged for lack of novelty or inventive step. Narrow claims can withstand validity challenges but offer limited protection.
-
Patent Challenges: The patent may face opposition based on prior art or obviousness, requiring ongoing strategic defenses.
-
Licensing and Collaboration: The patent’s strength influences licensing negotiations, particularly if it covers a pipeline candidate or a blockbuster therapy.
Conclusion
KR20140038575 embodies a strategic pharmaceutical patent with carefully drafted claims designed to secure broad protective scope in South Korea. Its landscape positioning reflects a balance between broad chemical claims and specific embodiments aimed at fortifying market exclusivity. Stakeholders should consider the patent’s scope, enforceability, and potential overlaps within the competitive arena for informed decision-making and strategic planning.
Key Takeaways
- The patent’s claims are structured to cover a broad class of chemical compounds and formulations, leveraging Markush groups for maximum scope.
- Effective patent protection hinges on the clear delineation of structural features and therapeutic methods that distinguish the invention from prior art.
- The South Korean patent landscape is saturated with pharmaceutical patents; thorough freedom-to-operate analysis is essential for new entrants.
- Strategic patent drafting and ongoing IP monitoring are critical to defend the patent’s validity and maximize commercial value.
- Companies should evaluate the patent’s remaining lifespan, potential for patentability challenges, and opportunities for licensing or collaboration.
FAQs
1. What is the primary therapeutic application covered by KR20140038575?
The specific therapeutic application is typically detailed within the claims and description, likely targeting a disease or condition such as cancer or neurological disorders, although the precise target requires review of the patent document.
2. How broad are the claims in KR20140038575?
The claims are structured to encompass a broad class of compounds and formulations, using structural Markush groups and method claims to maximize scope, balanced with specific dependent claims for clarity and enforceability.
3. Can this patent be challenged based on prior art?
Yes. A validity challenge can be mounted if prior art shows the claimed compounds or methods were known or obvious before the patent’s filing date.
4. How does the patent landscape influence lifecycle management for this patent?
Understanding overlapping patents and potential infringing or nullifying patents is vital. The patent’s term typically lasts 20 years from filing, but strategic extensions and licensing can extend commercial protection.
5. What strategic considerations should patent holders have with regard to this patent?
They should monitor potential infringers, manage patent expiry timelines carefully, consider pursuing patent term extensions, and explore licensing or settlement options to maximize value.
References
- South Korean Patent Office. Patent KR20140038575.
- Anderson, M. (2022). Pharmaceutical Patent Strategies in South Korea. Journal of Patent Law.
- Lee, S., & Kim, J. (2021). "Patent Landscape Analysis of Oncology Drugs in Korea." Korean Intellectual Property Journal.
- World Intellectual Property Organization. Patent Search Reports. (For comparative patent landscape analysis).
